Correlation Between Agilent Technologies and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Entero Therapeutics,, you can compare the effects of market volatilities on Agilent Technologies and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Entero Therapeutics,.
Diversification Opportunities for Agilent Technologies and Entero Therapeutics,
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agilent and Entero is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Agilent Technologies and Entero Therapeutics,
Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 0.17 times more return on investment than Entero Therapeutics,. However, Agilent Technologies is 5.93 times less risky than Entero Therapeutics,. It trades about 0.0 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.06 per unit of risk. If you would invest 14,928 in Agilent Technologies on August 27, 2024 and sell it today you would lose (1,544) from holding Agilent Technologies or give up 10.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agilent Technologies vs. Entero Therapeutics,
Performance |
| Timeline |
| Agilent Technologies |
| Entero Therapeutics, |
Agilent Technologies and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and Entero Therapeutics,
The main advantage of trading using opposite Agilent Technologies and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Agilent Technologies vs. Fonar | Agilent Technologies vs. Burning Rock Biotech | Agilent Technologies vs. Sera Prognostics | Agilent Technologies vs. Exagen Inc |
| Entero Therapeutics, vs. Cardinal Health | Entero Therapeutics, vs. Inflection Point Acquisition | Entero Therapeutics, vs. Aquestive Therapeutics | Entero Therapeutics, vs. Mangazeya Mining |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |